BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3615453)

  • 21. [The importance of middle molecules in assessing the level of endogenous intoxication (a review of the literature)].
    Kishkun AA; Kudinova AS; Ofitova AD; Mishurina RB
    Voen Med Zh; 1990 Feb; (2):41-4. PubMed ID: 2189262
    [No Abstract]   [Full Text] [Related]  

  • 22. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myocardial depressant factor in patients with low output syndrome].
    Senoo Y; Mondori E; Nawa S; Kawakami S; Teramoto S
    Kyobu Geka; 1977 Apr; 30(4):313-7. PubMed ID: 559194
    [No Abstract]   [Full Text] [Related]  

  • 24. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
    Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological modulation of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    J Chemother; 1989 Jul; 1(4 Suppl):469-72. PubMed ID: 16312489
    [No Abstract]   [Full Text] [Related]  

  • 26. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A circulating myocardial depressant substance in septic shock.
    Chest; 1990 Jun; 97(6):1502-3. PubMed ID: 2347245
    [No Abstract]   [Full Text] [Related]  

  • 28. A circulating myocardial depressant factor after shock.
    Fisher WD; McArdle CS; Maddern M; Ledingham IM
    Br J Surg; 1973 Apr; 60(4):308-9. PubMed ID: 4700243
    [No Abstract]   [Full Text] [Related]  

  • 29. Myocardial depressant substances in meningococcal septic shock.
    Kumar A; Parrillo JE
    Crit Care Med; 2002 Oct; 30(10):2379-80. PubMed ID: 12394974
    [No Abstract]   [Full Text] [Related]  

  • 30. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of heart performance with special emphasis on severe hemodynamic changes during hypovolemic-traumatic shock.
    Krösl P; Schlag G
    Prog Clin Biol Res; 1987; 236A():561-72. PubMed ID: 3615451
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac dynamics following shock: role of circulating cardiodepressant substances.
    Goldfarb RD
    Circ Shock; 1982; 9(3):317-34. PubMed ID: 7094223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple analysis of carnosine and anserine--it's application to traumatic shock.
    Kurisaki E; Hiraiwa K
    Fukushima J Med Sci; 1988 Jun; 34(1):11-9. PubMed ID: 3254857
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endogenous shock substances: research trends].
    Okada K
    Nihon Rinsho; 1980; 38(4):1836-42. PubMed ID: 7411893
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of a reticuloendothelial system-depressing substance produced in shock.
    Blattberg B; Frosolono MF; Misra RP; Levy MN
    J Reticuloendothel Soc; 1972 Oct; 12(4):371-86. PubMed ID: 4634517
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid-soluble cardiodepressant factor vs. water-soluble myocardial depressant factor-like substances in shock.
    Carli A
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H2100-2. PubMed ID: 1750556
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myocardial depressant factor in shock].
    Okada K; Kosugi I; Yamaguchi Y; Innami H; Kawashima Y
    Masui; 1973 May; 22(5):414-22. PubMed ID: 4737987
    [No Abstract]   [Full Text] [Related]  

  • 40. [High performance liquid chromatography of tumor-associated plasma peptides].
    Glinskiĭ GV; Glinskiĭ VV; Surmilo NI; Shvachko LP; Radavskiĭ IuL
    Dokl Akad Nauk SSSR; 1986; 288(2):495-9. PubMed ID: 3720505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.